Literature DB >> 17178800

Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands.

A Mazzariol1, E Roelofsen, R Koncan, A Voss, G Cornaglia.   

Abstract

A Klebsiella pneumoniae strain resistant to third-generation cephalosporins was isolated in the eastern Netherlands. The strain was found to carry a novel extended-spectrum beta-lactamase, namely, SHV-31. The combination of the two mutations by which SHV-31 differs from SHV-1, namely, L35Q and E240K, had previously only been described in association with one or more additional mutations.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17178800      PMCID： PMC1803151          DOI： 10.1128/AAC.00909-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.

Authors:  S K Bouchillon; B M Johnson; D J Hoban; J L Johnson; M J Dowzicky; D H Wu; M A Visalli; P A Bradford
Journal:  Int J Antimicrob Agents       Date:  2004-08       Impact factor: 5.283

2.  Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.

Authors:  J K Rasheed; C Jay; B Metchock; F Berkowitz; L Weigel; J Crellin; C Steward; B Hill; A A Medeiros; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals.

Authors:  E E Stobberingh; J Arends; J A Hoogkamp-Korstanje; W H Goessens; M R Visser; A G Buiting; Y J Debets-Ossenkopp; R J van Ketel; M L van Ogtrop; L J Sabbe; G P Voorn; H L Winter; J H van Zeijl
Journal:  Infection       Date:  1999 Nov-Dec       Impact factor: 3.553

4.  Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.

Authors:  C D Steward; J K Rasheed; S K Hubert; J W Biddle; P M Raney; G J Anderson; P P Williams; K L Brittain; A Oliver; J E McGowan; F C Tenover
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Patterns of resistance associated with integrons, the extended-spectrum beta-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak.

Authors:  Paul Gruteke; Wil Goessens; Jan Van Gils; Paul Peerbooms; Nicole Lemmens-Den Toom; Marga Van Santen-Verheuvel; Alex Van Belkum; Henri Verbrugh
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.

Authors:  D M Livermore; M Yuan
Journal:  J Antimicrob Chemother       Date:  1996-09       Impact factor: 5.790

7.  beta-Lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands.

Authors:  Henrik Hasman; Dik Mevius; Kees Veldman; Inger Olesen; Frank M Aarestrup
Journal:  J Antimicrob Chemother       Date:  2005-06-07       Impact factor: 5.790

8.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

9.  Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy.

Authors:  Laura Pagani; Emanuela Dell'Amico; Roberta Migliavacca; Marco Maria D'Andrea; Ernesto Giacobone; Gianfranco Amicosante; Egidio Romero; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948
  9 in total
  4 in total

1.  Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis.

Authors:  Brandt J Wiskur; Jonathan J Hunt; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-27       Impact factor: 4.799

2.  In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1.

Authors:  Hung-Jen Tang; Yee-Huang Ku; Mei-Feng Lee; Yin-Ching Chuang; Wen-Liang Yu
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

3.  Impact of single room design on the spread of multi-drug resistant bacteria in an intensive care unit.

Authors:  Teysir Halaby; Nashwan Al Naiemi; Bert Beishuizen; Roel Verkooijen; José A Ferreira; Rob Klont; Christina Vandenbroucke-Grauls
Journal:  Antimicrob Resist Infect Control       Date:  2017-11-15       Impact factor: 4.887

Review 4.  A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous.

Authors:  Apostolos Liakopoulos; Dik Mevius; Daniela Ceccarelli
Journal:  Front Microbiol       Date:  2016-09-05       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.